Cargando…
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
Matrix metalloproteinases (MMPs) were initially recognised for their extracellular matrix (ECM)-degrading capability during tissue remodelling. Their importance was further highlighted by their role in metastasis. Clinical trials have since evaluated the potential of MMP inhibitors as anticancer the...
Autores principales: | Hojilla, C V, Mohammed, F F, Khokha, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394437/ https://www.ncbi.nlm.nih.gov/pubmed/14612884 http://dx.doi.org/10.1038/sj.bjc.6601327 |
Ejemplares similares
-
Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer
por: Hojilla, Carlo V, et al.
Publicado: (2008) -
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
por: Overall, C M, et al.
Publicado: (2006) -
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016) -
Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013) -
Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases Are Essential for the Inflammatory Response in Cancer Cells
por: Sun, Jun
Publicado: (2010)